Literature DB >> 16351664

Tumor lysis syndrome in a patient with metastatic, androgen independent prostate cancer.

Jonathan L Wright1, Daniel W Lin, Puneet Dewan, R Bruce Montgomery.   

Abstract

Tumor lysis syndrome (TLS) is an uncommon, but well described, clinical entity that typically occurs following chemotherapy in patients with rapidly growing hematological malignancies. It is rarely described in patients with solid tumors. We report a case of TLS in a patient with metastatic adenocarcinoma of the prostate after treatment with paclitaxel chemotherapy.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16351664     DOI: 10.1111/j.1442-2042.2005.01196.x

Source DB:  PubMed          Journal:  Int J Urol        ISSN: 0919-8172            Impact factor:   3.369


  9 in total

Review 1.  Spontaneous tumour lysis syndrome.

Authors:  Natasha Kekre; Bojana Djordjevic; Claire Touchie
Journal:  CMAJ       Date:  2012-04-10       Impact factor: 8.262

2.  Tumor lysis syndrome in anti-androgen-treated metastatic prostate cancer.

Authors:  Sandra Mazzoni
Journal:  Int Urol Nephrol       Date:  2016-07-14       Impact factor: 2.370

3.  Spontaneous tumor lysis syndrome in a patient with metastatic prostate cancer.

Authors:  Naomi Serling-Boyd; Zoe Quandt; Nazima Allaudeen
Journal:  Mol Clin Oncol       Date:  2017-03-08

4.  Tumor lysis syndrome following cabazitaxel administration for metastatic castration-resistant prostate cancer: A case report.

Authors:  Masashi Oshima; Shozaburou Mayumi; Kai Yazaki; Yuuki Nakamura; Tsuzumi Konishi; Kimitoshi Saito; Satoshi Washino; Tomoaki Miyagawa
Journal:  IJU Case Rep       Date:  2019-04-15

5.  Tumor lysis syndrome after treatment with gemcitabine for metastatic transitional cell carcinoma.

Authors:  Cheng-Jui Lin; Ken-Hong Lim; Yi-Chou Cheng; Han-Hsiang Chen; Chih-Jen Wu
Journal:  Med Oncol       Date:  2007       Impact factor: 3.064

6.  An unusual presentation of tumor lysis syndrome in a patient with advanced gastric adenocarcinoma: case report and literature review.

Authors:  Danica Maria Vodopivec; Jose Enrique Rubio; Alessia Fornoni; Oliver Lenz
Journal:  Case Rep Med       Date:  2012-05-27

Review 7.  Intricate Interplay of Entwined Metabolic and Inflammatory Life-threatening Processes in Tumor Lysis Syndrome Complicating Prostate Cancer: A Systematic Review with a Single Institution Experience.

Authors:  Dawood Findakly; Jue Wang
Journal:  Cureus       Date:  2020-03-24

Review 8.  Tumor Lysis Syndrome in Solid Tumors: An up to Date Review of the Literature.

Authors:  Aibek E Mirrakhimov; Alaa M Ali; Maliha Khan; Aram Barbaryan
Journal:  Rare Tumors       Date:  2014-06-13

9.  Tumor lysis syndrome during radiotherapy for prostate cancer with bone and bone marrow metastases without visceral metastasis.

Authors:  Muhammet Ali Kaplan; Mehmet Kucukoner; Gulistan Alpagat; Abdurrahman Isikdogan
Journal:  Ann Saudi Med       Date:  2012 May-Jun       Impact factor: 1.526

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.